广州医科大学，简称广医，位于中国广州市，其始建于1958年，是一所以培养高等医学人才为目的，以医学为优势和特色的全日制高等医科院校，是国家“双一流”建设高校，也是现时13所广东省高水平大学之一。

During the past decade, The Fifth Affiliated Hospital of Guangzhou Medical University conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 1 clinical trials were completed, i.e. on average, 7.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Fifth Affiliated Hospital of Guangzhou Medical University" #1 sponsor was "Shenyang Sunshine Pharmaceutical Co., LTD." with 2 trials, followed by "Sun Yat-sen University" with 2 trials sponsored, "Dawnrays Pharmaceutical (Holdings) Limited" with 1 trials sponsored, "Genor Biopharma Co., Ltd." with 1 trials sponsored and "Janssen Research & Development, LLC" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Fifth Affiliated Hospital of Guangzhou Medical University" #1 collaborator was "Fifth Affiliated Hospital of Guangzhou Medical University" with 2 trials as a collaborator, "First Affiliated Hospital, Sun Yat-Sen University" with 2 trials as a collaborator, "Nanfang Hospital of Southern Medical University" with 2 trials as a collaborator, "Changsha Central Hospital" with 1 trials as a collaborator and "Changzhi People's Hospital" with 1 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 48 trials.

According to Clinical.Site data, the most researched conditions in "The Fifth Affiliated Hospital of Guangzhou Medical University" are "Anemia in Chronic Kidney Diseases" (1 trials), "Bone Tumor" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Coronary Artery Disease, Hypercholesterolemia, Hypertension" (1 trials) and "ESRD" (1 trials). Many other conditions were trialed in "The Fifth Affiliated Hospital of Guangzhou Medical University" in a lesser frequency.

Most popular intervention types in "The Fifth Affiliated Hospital of Guangzhou Medical University" are "Drug" (8 trials), "Biological" (2 trials), "Procedure" (2 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "16S rRNA gene sequencing of cervical secretions" (1 trials), "Amivantamab" (1 trials), "Carboplatin" (1 trials), "Colla corii asini" (1 trials) and "Conservative treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Fifth Affiliated Hospital of Guangzhou Medical University" are 10 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "The Fifth Affiliated Hospital of Guangzhou Medical University". undefined are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in The Fifth Affiliated Hospital of Guangzhou Medical University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Fifth Affiliated Hospital of Guangzhou Medical University, 5 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".